Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer

Cancer Res. 2022 Aug 26;OF1. doi: 10.1158/0008-5472.CAN-22-2507. Online ahead of print.
No abstract available

Publication types

  • Retraction of Publication